Xishan Technology announced on May 15, 2024 that as of May 10, 2024, the number of shareholders of the company was 5,312, an increase of 650 or 13.94% from the previous period (April 30, 2024).
The number of shareholders of Xishan Technology is lower than the industry average. According to Choice data, as of May 10, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000 ~ 15,000, accounting for the highest proportion, 29.05%, and Xishan Technology is also in the range.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 31, 2024, the number of shareholders of the company has decreased, with a decrease of 0.49%. From March 31, 2024 to May 10, 2024, the stock price decreased by 0.47%.
Number of shareholders and share price
Number of shareholders and share capital
As of May 10, 2024, the company's latest total share capital is 53,001,500 shares, of which the outstanding share capital is 12,818,700 shares. The average number of outstanding shares held by households decreased from 2,750 shares in the previous period to 2,413 shares, and the average market value of households was 173,200 yuan.
The average amount of shares held by each household
The average circulating market value of Xishan Technology households is lower than the industry average. According to Choice data, as of May 10, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 402,300 yuan. Among them, 25.31% of the company's households hold a circulating stock market value of 130,000~250,000 yuan, and Xishan Technology is also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.